HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 757-768 of 1,811
Drug study icon
CompletedNCT00249353

Effectiveness of CONCERTA® (Methylphenidate Hydrochloride) in ADHD

What is this study about?

This study evaluated the safety and effectiveness of methylphenidate hydrochloride for people with ADHD.

This study has finished and is no longer accepting participants.

Location not clearly listed
ADHDMedication studyAges 13–18
Countries
Sponsor
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Drug study icon
CompletedNCT01060150

An Efficacy Study of Osmotic Release Oral System (OROS) Methylphenidate in people with Attention-Deficit/Hyperactivity Disorder (ADHD)

Official study title

Efficacy and Learning Skill After OROS Methylphenidate Treatment in Adolescents With Attention-Deficit/Hyperactivity Disorder: A 12-week, Multi-center, Open-label Study

This study has finished and is no longer accepting participants.

Location not clearly listed
ADHDMedication studyAges 12–18
Countries
Sponsor
Janssen Korea, Ltd., Korea
Drug study icon
CompletedNCT04167995

Assessment of Probiotics Lactobacillus in the Management of Attention Deficit Hyperactive Disorder

Official study title

Assessment of Probiotic Strain Lactobacillus Acidophilus LB Supplementation as Adjunctive Management of Attention-deficit Hyperactivity Disorder in Children and Adolescents: a Randomized Controlled Clinical Trial

This study has finished and is no longer accepting participants.

In Cairo
ADHDMedication studyAges 6–16
Countries
Egypt
Sponsor
Ain Shams University
Drug study icon
CompletedNCT00380692

Atomoxetine Versus Placebo for Symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents With Autism Spectrum Disorder

What is this study about?

Researchers compared atomoxetine and placebo to find out how the approaches affected ADHD symptoms in children and adolescents with ADHD.

This study has finished and is no longer accepting participants.

Multiple locations, including Amsterdam
ADHDMedication studyAges 6–17
Countries
Netherlands
Sponsor
Eli Lilly and Company

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.